Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.

<h4>Background</h4>Patients with cirrhosis and acute myocardial infarction (AMI) present dilemma whether dual antiplatelet therapy (DAPT) should be used.<h4>Methods</h4>Electronic medical records between 2001-2013 were retrieved from Taiwan National Health Insurance Research...

Full description

Bibliographic Details
Main Authors: Victor Chien-Chia Wu, Shao-Wei Chen, An-Hsun Chou, Pei-Chi Ting, Chih-Hsiang Chang, Michael Wu, Ming-Jer Hsieh, Chao-Yung Wang, Shang-Hung Chang, Ming-Shyan Lin, Kuo-Chun Hung, I-Chang Hsieh, Pao-Hsien Chu, Cheng-Shyong Wu, Yu-Sheng Lin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0223380